(Q33869507)

29 July 2017

C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma (English)

1 reference

29 July 2017

0 references

Thomas Gerhardt

1

1 reference

29 July 2017

Sabine Milz

2

1 reference

29 July 2017

Michael Schepke

3

1 reference

29 July 2017

Georg Feldmann

4

1 reference

29 July 2017

Martin Wolff

5

1 reference

29 July 2017

Tilman Sauerbruch

6

1 reference

29 July 2017

Franz Ludwig Dumoulin

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

5495-5500

1 reference

29 July 2017

34

1 reference

Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

The role of chemotherapy in cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Transplantation for hilar cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Surgical management of cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

The epidemiology of cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

What constitutes long-term survival after surgery for hilar cholangiocarcinoma?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Liver, gallbladder, extrahepatic bile ducts, and pancreas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Choledochal cyst disease. A changing pattern of presentation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Serum C-reactive protein levels in disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

International variations in epidemiology of cancers of the extrahepatic biliary tract

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Management Strategies in Resection for Hilar Cholangiocarcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4088232

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Liver transplantation for unresectable perihilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I34.5495

Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers

21 January 2018

1 reference

12 December 2020

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

12 December 2020

Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma

1 reference

12 December 2020

Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker

1 reference

12 December 2020

Acute-phase protein response and survival duration of patients with pancreatic cancer

1 reference

12 December 2020

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I34.5495

1 reference

29 July 2017

1 reference

29 July 2017

1 reference